Northeastern University Distinguished Professor Kim Lewis and his team’s pioneering research presenting a new antibiotic that kills pathogens without encountering any detectable resistance has captured headlines worldwide and drawn widespread praise from the scientific community.
Associate professor of chemistry and chemical biology Michael Pollastri has received a five-year, $2.5 million grant from the National Institutes of Health to advance his research into a treatment for sleeping sickness.
The neglected tropical disease affects tens of thousands of people and is mostly fatal. Now, new research co-authored by Northeastern chemistry professor Michael Pollastri has identified hundreds of chemical compounds that could lead to a cure.
New research from the Center for Drug Discovery at Northeastern presents a series of molecules that can be controllably deactivated, thereby reducing the side effects of potentially valuable drugs.
At the sixth event in Northeastern’s Women Who Inspire series, CEOs of three of the area’s top pharmaceutical companies discussed the challenges and rewards of being a leader in the drug discovery industry.
Fifth-year chemistry major Mark Naniong’s research while on co-op at the Dana-Farber Cancer Institute made it to the pages of a prestigious academic journal—and inspired him to pursue a career linked to innovation in science.
New research from physics professor Mark Williams stands to transform HIV/AIDS drug discovery by elucidating a long-held paradox about the molecules that form our first line of immune defense against the virus.
At a symposium hosted by Northeastern on Tuesday, a pioneering chemist marveled at the human body’s ability to flourish in the face of exposure to thousands of harmful pathogens.
Director of Northeastern’s Antimicrobial Discovery Center elected to the American Academy of Microbiology on the strength of his research achievements